Johnson_1995_Mol.Pharmacol_48_194

Reference

Title : alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors - Johnson_1995_Mol.Pharmacol_48_194
Author(s) : Johnson DS , Martinez J , Elgoyhen AB , Heinemann SF , McIntosh JM
Ref : Molecular Pharmacology , 48 :194 , 1995
Abstract :

Through a study of cloned nicotinic receptors expressed in Xenopus oocytes, we provide evidence that alpha-conotoxin ImI, a peptide marine snail toxin that induces seizures in rodents, selectively blocks subtypes of nicotinic acetylcholine receptors. alpha-Conotoxin ImI blocks homomeric alpha 7 nicotinic receptors with the highest apparent affinity and homomeric alpha 9 receptors with 8-fold lower affinity. This toxin has no effect on receptors composed of alpha 2 beta 2, alpha 3 beta 2, alpha 4 beta 2, alpha 2 beta 4, alpha 3 beta 4, or alpha 4 beta 4 subunit combinations. In contrast to alpha-bungarotoxin, which has high affinity for alpha 7, alpha 9, and alpha 1 beta 1 gamma delta receptors, alpha-conotoxin ImI has low affinity for the muscle nAChR. Related Conus peptides, alpha-conotoxins MI and GI, exhibit a distinct specificity, strictly targeting the muscle subtype receptor but not alpha 7 or alpha 9 receptors. alpha-Conotoxins thus represent selective tools for the study of neuronal nicotinic acetylcholine receptors.

PubMedSearch : Johnson_1995_Mol.Pharmacol_48_194
PubMedID: 7651351

Related information

Citations formats

Johnson DS, Martinez J, Elgoyhen AB, Heinemann SF, McIntosh JM (1995)
alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors
Molecular Pharmacology 48 :194

Johnson DS, Martinez J, Elgoyhen AB, Heinemann SF, McIntosh JM (1995)
Molecular Pharmacology 48 :194